Fundatia Dr. Victor Babes
- Address
- Soseaua Mihai Bravu 281, 030303 Bucharest, Romania
Fundatia Dr. Victor Babes - Metabolic and Respiratory Disease Research Center
Fundatia Dr. Victor Babes is a distinguished clinical research center specializing in metabolic disorders and respiratory diseases. The center demonstrates particular expertise in conducting Phase 2 and Phase 3 clinical trials, focusing on innovative therapeutic approaches for chronic conditions that significantly impact public health. Their research portfolio reflects a commitment to advancing treatment options for complex metabolic and pulmonary conditions.
- Chronic Obstructive Pulmonary Disease (COPD) - evaluation of novel biologics for exacerbation reduction and disease control
- Metabolic disorders including Non-Alcoholic Steatohepatitis (NASH) and obesity management with comorbidities
- Acute respiratory conditions including pneumonia and infectious disease research
The center's respiratory medicine program has established significant experience in evaluating biologic therapies for COPD, including monoclonal antibodies targeting disease exacerbations. In the metabolic disease arena, Fundatia Dr. Victor Babes conducts comprehensive studies on NASH with fibrosis and weight management interventions, incorporating both pharmacological agents and lifestyle modifications. Their participation in international collaborative studies, such as the RECOVERY trial for pneumonia, underscores their capability to contribute to urgent global health initiatives while maintaining rigorous clinical research standards.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Can-Fite Biopharma Ltd.1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Metsera Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Fundatia Dr. Victor Babes
lock Showing 1 of 9 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Astegolimab in Chronic Obstructive Pulmonary Disease: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study | Genentech Inc. | Phase II | Not Recruiting | Jan 2022 | Feb 2025 |
IMP list
lock Showing 1 of 13 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Baloxavir Marboxil | 1 | Unknown | 2024-02-29 | 2024-02-29 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.